Jodi Pantuck, BBA
Jodi is the Chief of Staff and Operations at Athos Therapeutics Inc. She worked as a CPA for many years in New York before relocating to Los Angeles. She has experience with all aspects of financial accounting and ensures that the books and records of Athos are accurate and are recorded in accordance with GAAP […]
Abraham Verghese, MD, MACP
Abraham Verghese MD is the Linda R. Meier and Joan F. Lane Provostial Professor, and Vice Chair of the Department of Medicine at Stanford University School of Medicine. His training is in infectious diseases and pulmonary medicine. At Stanford, in addition to seeing inpatients and teaching medical students, he runs PRESENCE, a multidisciplinary project that […]
Keith B. Hoffman, PhD
Dr. Hoffman is the Chief Business Officer of Athos Therapeutics Inc. Prior to Athos, he was the Senior Vice President of Business Development and Technology Transfer at the Lundquist Institute for Biomedical Innovation at the Harbor-UCLA Medical Center, a research institute with over 400 scientists and 600 research projects. Keith oversaw all commercialization, licensing, startup […]
Dimitrios Iliopoulos, PhD MBA
Dr. Dimitrios Iliopoulos is the President, CEO and a co-Founder of Athos Therapeutics Inc. He started his academic career at Harvard Medical School where he was an Assistant Professor of Microbiology & Immunology. More recently, he was a tenured Associate Professor of Medicine at UCLA School of Medicine and Founder & Director of the UCLA […]
Allan J. Pantuck, MD MS
Dr. Allan Pantuck is the Chairman, co-Founder, and Chief Medical Officer of Athos Therapeutics Inc. He was a co-founder of Kite Pharma, a biotech company that successfully developed and obtained FDA approval for an innovative cancer immunotherapy and was acquired from Gilead Sciences in 2017. He is currently a Professor of Urology at UCLA David […]
Michael Jung, PhD
Dr. Michael Jung is a co-Founder and a member of the Scientific Advisory Board (SAB) of Athos Therapeutics Inc. He is a world-renowned medicinal chemist serving on the Scientific Advisory Boards of numerous biotech and pharmaceutical firms. He is an authority on synthetic organic and medicinal chemistry, holding more than 25 patents and being elected […]
Allan J. Pantuck, MD MS
Dr. Allan Pantuck is the Chairman, co-Founder, and Chief Medical Officer of Athos Therapeutics Inc. He was a co-founder of Kite Pharma, a biotech company that successfully developed and obtained FDA approval for an innovative cancer immunotherapy and was acquired from Gilead Sciences in 2017. He is currently a Professor of Urology at UCLA David […]
Dimitrios Iliopoulos, PhD MBA
Dr. Dimitrios Iliopoulos is the President, CEO and a co-Founder of Athos Therapeutics Inc. He started his academic career at Harvard Medical School where he was an Assistant Professor of Microbiology & Immunology. More recently, he was a tenured Associate Professor of Medicine at UCLA School of Medicine and Founder & Director of the UCLA […]
Julian Panes, MD
Dr. Panes is Professor of Medicine and the Chief of the Department of Gastroenterology at Hospital Clinic de Barcelona. His research team works on the identification of new molecular targets for the treatment of inflammatory bowel diseases, the development of cell therapies and the implementation of new diagnostic tools, with a particular focus on cross-sectional […]
Silvio Danese, MD, PhD
Dr. Danese is Full Professor of Gastroenterology at Humanitas University and Head of the IBD Center at the Humanitas Research Hospital in Italu. Dr. Danese graduated from the Catholic University “Sacro Cuore” of Rome in 1999. From 2001 to 2004, he moved in the Division of Gastroenterology at Case Western Reserve University, Cleveland, where he […]